VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2021 Earnings Conference Call June 29, 2021 5:00 PM ET
Company Participants
Mark Flather - Vice President of Investor Relations
Shawn Singh - Chief Executive Officer
Jerrold Dotson - Vice President, Chief Financial Officer and Secretary
Mark Smith - Chief Medical Officer
Conference Call Participants
Tim Lugo - William Blair
Brian Skorney - Robert W. Baird
Andrew Tsai - Jefferies
Jason McCarthy - Maxim Group
Operator
Greetings. Welcome to VistaGen Therapeutics Fiscal Year 2021 Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A Question-And-Answer Session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Mark Flather, Vice President of Investor Relations. Thank you. You may begin.
Mark Flather
Thank you, Sherry. Hello and welcome to the VistaGen Therapeutics 2021 fiscal year end financial results and corporate update conference call. I am Mark Flather, Vice President of Investor Relations of VistaGen. Thank you for joining us today for this business update and welcome to our shareholders, analysts and anyone taking an interest in VistaGen.
Joining me today is Shawn Singh, our Chief Executive Officer; Jerry Dotson, our Chief Financial Officer; and Dr. Mark Smith, our Chief Medical Officer. The format for this call will consist of prepared remarks from the management, followed by an opportunity for questions. This call is being webcast and will be available for replay. The link can be found in the Investors IR Calendar section of our website vistagen.com.
On today’s call we will make forward-looking statements regarding our business based on our current expectations and current information. The forward-looking statements speak only as of today and except as required by law, we do not assume any duty to update in the future
- Read more current VTGN analysis and news
- View all earnings call transcripts